Osteoporosis; Teriparatide is expensive but effective against bone loss
Osteoporosis; Teriparatide is expensive but effective against bone loss
About this item
Full title
Osteoporosis; Teriparatide is expensive but effective against bone loss
Publisher
Atlanta: NewsRx
Journal title
Biotech Business Week, 2004, p.5
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
According to H. Dobnig and colleagues, "With the introduction of teriparatide [rhPTH(1-34)], a recombinant formulation of parathyroid hormone (PTH) consisting of the first 34 amino acids of the N- terminal region, bone-forming therapy has now become possible. Preclinical, as well as human studies, have shown increases in trabecular as well as corti...
Alternative Titles
Full title
Osteoporosis; Teriparatide is expensive but effective against bone loss
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_236098773
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_236098773
Other Identifiers
ISSN
1543-687X
E-ISSN
1543-6861
How to access this item
Log in as a Library member
